The meeting will start promptly at 10:00 and is expected to finish at approximately 14:00
Venue: At NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT
1. Welcome and introduction to format of meeting
3. Any other business
4. Minutes from the last meeting held 11 December 2014
5. Evaluation of eculizumab for the treatment of atypical haemolytic uraemic syndrome (aHUS)
5.1. Declarations of interest - Part 1 only (open session)
5.2. Introduction by the Chair, Dr Peter Jackson - Part 1 only (open session)
5.3. Presentation by the Chair, Dr Peter Jackson - Part 1 and Part 2 (open and closed session)
5.4.Agreement on the content of the Evaluation Consultation Document (ECD) or Final Evaluation Determination (FED) - Part 2 only (closed session)
PDF version of agenda (opens in new window)
Next HST Evaluation Meeting: Wednesday 26 November 2014 at 10:00am, NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT.
Please note all timings are approximate.